Home
About Lectranal®
Research
Product supply
About us
FAQ
News
Events
LECTRANAL® MARKETS
Contact us
CLINICAL TRIAL ON LECTRANAL® COMPLETED
17.12.2007.
A double-blind placebo controlled clinical trial confirms efficacy and safety of Lectranal® in treating seasonal allergic rhinitis.
Over a period of 6 weeks 78.6% of patients in the Lectranal® group had significant or moderate improvement compared to 38.5% in the placebo group. Lectranal® had statistical significantly better results for several outcome measures in comparison to the placebo. Lectranal® had strong positive effect on the reduction of SARS and Mini RQLQ score as well as on the improvement in individual allergy symptoms. more
Disclaimer | General Conditions Of Use | Privacy Statement | Imprint All rights reserved, Lectranal 2006

This website is intended for business to business communication only.
Distributors of the finished products are responsible for ensuring that the claims made
for and use of their products comply with the regulatory requirements of the location.
Owner of the page takes no responsibility for the misuse of the claims.
Design by: Studio2M       Powered by: CorvusCMS